Macrogenics (MGNX) Other Operating Expenses (2021 - 2026)

Macrogenics (MGNX) has reported Other Operating Expenses for 6 consecutive years, with $9.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 76.48% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $40.1 million (up 157.59% YoY), while the FY2025 annual figure was $36.0 million, up 192.78% from the prior year.
• Other Operating Expenses fell to $9.5 million in Q1 2026 per MGNX's latest filing, from $10.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $11.6 million in Q3 2025 and bottomed at $48000.0 in Q1 2022.
• Historically, Other Operating Expenses has averaged $4.3 million across 5 years, with a median of $3.1 million in 2022.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 10818.18% — and 2023, when it tumbled 90.9%.
• Macrogenics' Other Operating Expenses stood at $1.8 million in 2022, then sank by 90.9% to $163000.0 in 2023, then jumped by 3268.1% to $5.5 million in 2024, then jumped by 84.24% to $10.1 million in 2025, then slipped by 5.78% to $9.5 million in 2026.
• Business Quant data shows MGNX's Other Operating Expenses at $9.5 million in Q1 2026, $10.1 million in Q4 2025, and $11.6 million in Q3 2025.